| 1 |
Prognostic value of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and aminopeptidase N/CD13 in breast cancer patients |
|
|
| Irena Ranogajec, Jasminka Jakić-Razumović, Velibor Puzović, Jelka Gabrilovac |
|
| Medical Oncology. 2012; 29(2): 561 |
|
| [HTML Full text] [Google Scholar] |
|
| 2 |
TGF-β1 modulates the homeostasis between MMPs and MMP inhibitors through p38 MAPK and ERK1/2 in highly invasive breast cancer cells |
|
|
| Luciana R Gomes, Letícia F Terra, Rosângela AM Wailemann, Leticia Labriola, Mari C Sogayar |
|
| BMC Cancer. 2012; 12(1): 26 |
|
| [HTML Full text] [Google Scholar] |
|
| 3 |
Obesity-related systemic factors promote an invasive phenotype in prostate cancer cells |
|
|
| R S Price, D A Cavazos, R E De Angel, S D Hursting, L A deGraffenried |
|
| Prostate Cancer and Prostatic Diseases. 2012; |
|
| [HTML Full text] [Google Scholar] |
|
| 4 |
Clinical relevance of cyclooxygenase-2 and matrix metalloproteinases (MMP-2 and MT1-MMP) in human breast cancer tissue |
|
|
| Mohammad A. Mohammad, Ahmed A. Zeeneldin, Zakaria Y. Abd Elmageed, Ebtsam H. Khalil, Said M. E. Mahdy, Hayat M. Sharada, Sabry K. Sharawy, Abdel-Hady A. Abdel-Wahab |
|
| Molecular and Cellular Biochemistry. 2012; |
|
| [HTML Full text] [Google Scholar] |
|
| 5 |
<i>MMP-9</i> expression in peripheral blood mononuclear cells and the association with clinicopathological features and prognosis of nasopharyngeal carcinoma |
|
|
| Jian-Rong He, Han Qin, Ze-Feng Ren, Cui Cui, Ying Zhang, Dharshana Ranatunga, Yi-Xin Zeng, Wei-Hua Jia |
|
| Clinical Chemistry and Laboratory Medicine. 2011; 49(4): 705 |
|
| [HTML Full text] [Google Scholar] |
|
| 6 |
Status of research on MMPs in India |
|
|
| Chinnadurai Saravanan, Sushil Kumar Singh |
|
| Expert Opinion on Therapeutic Targets. 2011; : 1 |
|
| [HTML Full text] [Google Scholar] |
|
| 7 |
Status of research on MMPs in India |
|
|
| Saravanan, C., Singh, S.K. |
|
| Expert Opinion on Therapeutic Targets. 2011; 15(6): 715-728 |
|
| [Pubmed] [Google Scholar] |
|
| 8 |
Canine mammary tumours as a model to study human breast cancer: Most recent findings |
|
|
| Queiroga, F.L., Raposo, T., Carvalho, M.I., Prada, J., Pires, I. |
|
| In Vivo. 2011; 25(3): 455-465 |
|
| [Pubmed] [Google Scholar] |
|
| 9 |
Clinical effect of neoadjuvant chemotherapy combined with pa-msha injection on breast cancer |
|
|
| Mao, Q., Zhang, M., Hao, X., Zhang, S., Zhang, J. |
|
| Chinese Journal of Clinical Oncology. 2010; 37(2): 117-120 |
|
| [Pubmed] [Google Scholar] |
|
| 10 |
Aggressive mammary carcinoma progression in Nrf2 knockout mice treated with 7,12-dimethylbenz[a]anthracene |
|
|
| Becks, L., Prince, M., Burson, H., Christophe, C., Broadway, M., Itoh, K., Yamamoto, M., (...), Kleiner-Hancock, H.E. |
|
| BMC Cancer. 2010; 10(art 540) |
|
| [Pubmed] [Google Scholar] |
|
| 11 |
Tissue inhibitor of metalloproteinase-2 regulates matrix metalloproteinase-2-mediated endothelial barrier dysfunction and breast cancer cell transmigration through lung microvascular endothelial cells |
|
|
| Shen, Q., Lee, E.S., Pitts, R.L., Wu, M.H., Yuan, S.Y. |
|
| Molecular Cancer Research. 2010; 8(7): 939-951 |
|
| [Pubmed] [Google Scholar] |
|
| 12 |
MMP inhibition blocks fibroblast-dependent skin cancer invasion, reduces vascularization and alters VEGF-A and PDGF-BB expression |
|
|
| Woenne, E.C., Lederle, W., Zwick, S., Palmowski, M., Krell, H., Semmler, W., Mueller, M.M., Kissling, F. |
|
| Anticancer Research. 2010; 30(3): 703-712 |
|
| [Pubmed] [Google Scholar] |
|
| 13 |
Matrix Metalloproteinases and Their Inhibitors: Correlation with Invasion and Metastasis in Oral Cancer |
|
|
| Ragini D. Singh, N. Haridas, Jayendra B. Patel, Franky D. Shah, Shilin N. Shukla, Pankaj M. Shah, Prabhudas S. Patel |
|
| Indian Journal of Clinical Biochemistry. 2010; 25(3): 250 |
|
| [HTML Full text] [Google Scholar] |
|
